IQVIA Holdings, Inc. (IQV): Valuation
TTM figures as of March 31, 2026
IQVIA Holdings, Inc. trades at 31.1 times trailing earnings and a 4.91% free-cash-flow yield. On P/E that is higher than 51% of its own month-end history back to 2013. The Healthcare median P/E is 22.9.
Earnings yield 3.21%. Shareholder yield 3.30%. ROIC 9.2%. Net debt $13.7B.
160 month-end valuation observations are on file, starting May 2013.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is IQV cheap versus its own history?
IQVIA Holdings, Inc. trades at 31.1 times trailing earnings and a 4.91% free-cash-flow yield. On P/E that is higher than 51% of its own month-end history back to 2013. The Healthcare median P/E is 22.9.
What is IQV's free-cash-flow yield?
IQVIA Holdings, Inc. currently yields 4.91% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.